July 21, 2020
United States Securities and Exchange Commission
100 F Street, N.E.
Mail Stop 4720
Washington, D.C. 20549
Attention: Alan Campbell and Joe McCann
| Re: | iTeos Therapeutics, Inc. |
Registration Statement on Form S-1 (File No. 333-239415)
Request for Acceleration
Dear Mr. Campbell and Mr. McCann:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that as of the date hereof, approximately 2,105 copies of the Preliminary Prospectus dated July 20, 2020 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Thursday, July 23, 2020 or as soon thereafter as practicable.
[Signature page follows]
| Very truly yours,
J.P. MORGAN SECURITIES LLC SVB LEERINK LLC PIPER SANDLER & CO.
As representatives of the Underwriters
J.P. MORGAN SECURITIES LLC | ||
| By: | /s/ David Ke | |
| Name: David Ke Title: Executive Director | ||
| SVB LEERINK LLC | ||
| By: | /s/ Irena Melnikova | |
| Name: Irena Melnikova Title: Managing Director | ||
| PIPER SANDLER & CO. | ||
| By: | /s/ David Stadinski | |
| Name: David Stadinski Title: Managing Director | ||
[Signature Page to Acceleration Request]